{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:21:34Z","timestamp":1790749294099,"version":"4.1.0"},"reference-count":89,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,10,20]],"date-time":"2009-10-20T00:00:00Z","timestamp":1255996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:sec><jats:label\/><jats:p><jats:italic>J. Neurochem.<\/jats:italic>(2010)<jats:bold>112<\/jats:bold>, 112\u2013122.<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p>There is substantial evidence that abnormal concentrations of oxidised tryptophan metabolites, produced via the kynurenine pathway, contribute to progressive neurodegeneration in Huntington\u2019s disease. We have now examined the blood levels of these metabolites in patients at different stages of Huntington\u2019s disease, assessed both in terms of clinical disease severity and numbers of CAG repeats. Close relatives of the patients were included in the study as well as unrelated healthy controls. Levels of lipid peroxidation products, the pro\u2010inflammatory cytokine interleukin (IL)\u201023 and the soluble human leucocyte antigen\u2010G (sHLA\u2010G) were also measured. There were lower levels of tryptophan and a higher kynurenine\u2003:\u2003tryptophan ratio, indicating activation of indoleamine\u20102,3\u2010dioxygenase, in the most severely affected group of patients, with increased levels of IL\u201023 and sHLA\u2010G. Marked correlations were noted between IL\u201023 and the patient severity group, anthranilic acid levels and the number of CAG repeats, and between anthranilic acid and IL\u201023, supporting our previous evidence of a relationship between anthranilic acid and inflammatory status. Tryptophan was negatively correlated with symptom severity and number of CAG repeats, and positively correlated with sHLA\u2010G. The results support the proposal that tryptophan metabolism along the kynurenine pathway in Huntington\u2019s disease is related to the degree of genetic abnormality, to clinical disease severity and to aspects of immunopathogenesis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1471-4159.2009.06442.x","type":"journal-article","created":{"date-parts":[[2009,10,20]],"date-time":"2009-10-20T04:37:11Z","timestamp":1256013431000},"page":"112-122","source":"Crossref","is-referenced-by-count":78,"title":["Blood levels of kynurenines, interleukin\u201023 and soluble human leucocyte antigen\u2010G at different stages of Huntington\u2019s disease"],"prefix":"10.1111","volume":"112","author":[{"given":"Caroline M.","family":"Forrest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Stoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Spiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Gail","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13304-1"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/321168a0"},{"key":"e_1_2_7_4_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1523\/JNEUROSCI.11-01-00147.1991","article-title":"Neurochemical characterization of excitotoxin lesions in the cerebral cortex","volume":"11","author":"Beal M. F.","year":"1991","journal-title":"J. Neurosci."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90191-M"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080178"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0886-6"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1999.tb00216.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0708446"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00431-4"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(03)00091-8"},{"key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA\u2010G: from biology to clinical benefits","volume":"29","author":"Carosella E. D.","year":"2003","journal-title":"Trends Immunol."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(03)81006-4"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4619-08.2008"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24446"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05838.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90216-3"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01101711"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1191\/1352458506ms1241oa"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-057125"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2006.04490.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb03460.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200202)32:2<311::AID-IMMU311>3.0.CO;2-8"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02917-0"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1542"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.105.040089"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(00)00956-3"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2101"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-007-9463-1"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5599-08.2009"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00341-X"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00494-P"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00724-6"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.106762"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(93)90171-X"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(94)00280-2"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/7.2.195"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000086295"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02224.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1998.132"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.01.007"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.01.001"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01220.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03215.x"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.02.004"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00405.x"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5380.1191"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.71.183"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.22.12553"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.70010299.x"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90749-W"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.11.037"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(82)91048-4"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2006.01.020"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2007.07.004"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)90109-0"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-579X(03)00028-2"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90987-2"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e328304b692"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.2.161"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1999.0447"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.034439"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6849138"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.11.4079"},{"key":"e_1_2_7_69_1","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease","author":"Schwarcz R.","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320309"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)83173-4"},{"key":"e_1_2_7_72_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"The neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone T. W.","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00032-0"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05540.x"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd870"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90587-2"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199406020-00026"},{"key":"e_1_2_7_78_1","first-page":"247","volume-title":"Antigen Presenting Cells: From Mechanisms to Drug Development","author":"Stoy N. S.","year":"2005"},{"key":"e_1_2_7_79_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/3527607021.ch10","volume-title":"Antigen Presenting Cells: from Mechanisms to Drug Development","author":"Stoy N. S.","year":"2005"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03070.x"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199505300-00013"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1570"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110204"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.5.839"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90211-J"},{"key":"e_1_2_7_87_1","first-page":"17","article-title":"Effects of kynurenine and probenecid on plasma and brain tissue concentrations of kynurenic acid","volume":"1","author":"Vecsei L.","year":"1992","journal-title":"Neurodegeneration"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2006.10.021"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh609"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408936102"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2009.06442.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2009.06442.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T20:58:31Z","timestamp":1739393911000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2009.06442.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,8]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1471-4159.2009.06442.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06442.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,8]]}}}